Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 312Pancreatic Neoplasms 176Carcinoma, Hepatocellular 117Stomach Neoplasms 114Esophageal Neoplasms 83Carcinoma, Non-Small-Cell Lung 82Colonic Neoplasms 81Rectal Neoplasms 73Breast Neoplasms 73Ovarian Neoplasms 61Neoplasm Metastasis 60Lung Neoplasms 57Neoplasms 55Cholangiocarcinoma 53Gastrointestinal Neoplasms 45Melanoma 44Liver Neoplasms 43Prostatic Neoplasms 40Endometrial Neoplasms 33Squamous Cell Carcinoma of Head and Neck 32Sarcoma 32Biliary Tract Neoplasms 32Carcinoma, Renal Cell 30Esophageal Squamous Cell Carcinoma 28Uterine Cervical Neoplasms 26Head and Neck Neoplasms 24Urinary Bladder Neoplasms 23Adenocarcinoma Of Esophagus 23Small Cell Lung Carcinoma 20Triple Negative Breast Neoplasms 17

Interventions

Sodium Chloride 1Amiodarone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Atrial Fibrillation × Gastrointestinal × 30 days × Clear all
NCT06067438 2026-05-22

Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer

OHSU Knight Cancer Institute

Phase 2 Recruiting
90 enrolled
Gastrointestinal

Atrial Fibrillation, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡